List of Zipsor drug patents

Zipsor is owned by Assertio.

Zipsor contains Diclofenac Potassium.

Zipsor has a total of 6 drug patents out of which 0 drug patents have expired.

Zipsor was authorised for market use on 16 June, 2009.

Zipsor is available in capsule;oral dosage forms.

Zipsor can be used as diclofenac potassium for relief of mild to moderate acute pain, nonsteroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain.

The generics of Zipsor are possible to be released after 24 February, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7884095 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US8110606 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US7662858 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US7939518 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US8623920 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US9561200 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

Exclusivity Exclusivity Expiration
New Patient Population (NPP) May 25, 2024

Drugs and Companies using DICLOFENAC POTASSIUM ingredient

Market Authorisation Date: 16 June, 2009

Treatment: Nonsteroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain; Diclofenac potassium for relief of mild to moderate acute pain

Dosage: CAPSULE;ORAL

How can I launch a generic of ZIPSOR before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in